WASH debuts on MAI, targeting 160 new branches for 2026-2027 
Shoucheng Holdings Launches Robot Tech Experience Store Naming Event 
EdgePoint Marks Five Years of Building ASEAN’s Digital Connectivity, with 16,000th site milestone 
Think Business, Think Hong Kong returns to Milan to deepen Hong Kong-Italy business ties 
Doubleview Gold Corp. Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of $7,181,400 Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
Customer Cash Receipts (A$’000) Customer Cash Receipts (A$’000) MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE)…
Abeona Therapeutics Announces Submission of Briefing Package for Pre-Biologics License Application (BLA) Meeting with FDA in August 2023
CLEVELAND, July 28, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that…
Abeona Therapeutics Announces Submission of Briefing Package for Pre-Biologics License Application (BLA) Meeting with FDA in August 2023
CLEVELAND, July 28, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that…
Avicanna is Pleased to Announce the Initial Network of Brands on the MyMedi.ca Platform
The MyMedi.ca medical cannabis care platform is preparing to launch August 1, 2023 The new…
Avicanna is Pleased to Announce the Initial Network of Brands on the MyMedi.ca Platform
The MyMedi.ca medical cannabis care platform is preparing to launch August 1, 2023 The new…
Press release: Online availability of Sanofi’s half-year financial report for 2023
Online availability of Sanofi’s half-year financial report for 2023 Paris, July 28, 2023. Sanofi announces…
Press release: Online availability of Sanofi’s half-year financial report for 2023
Online availability of Sanofi’s half-year financial report for 2023 Paris, July 28, 2023. Sanofi announces…
Mendus raises approximately SEK 317 million through the directed issue to Flerie and a fully secured rights issue
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN…
Mendus raises approximately SEK 317 million through the directed issue to Flerie and a fully secured rights issue
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN…
Biogen to Acquire Reata Pharmaceuticals
SKYCLARYS® recently approved in US as the only treatment indicated for patients with Friedreich’s ataxia …
Biogen to Acquire Reata Pharmaceuticals
SKYCLARYS® recently approved in US as the only treatment indicated for patients with Friedreich’s ataxia …
OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center
OKYO plans a 40-patient OK-101 open-label clinical trial with Dr Pedram Hamrah, Tufts Medical Center,…
OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center
OKYO plans a 40-patient OK-101 open-label clinical trial with Dr Pedram Hamrah, Tufts Medical Center,…
AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023
AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023 Lausanne, Switzerland, July 28,…
AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023
AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023 Lausanne, Switzerland, July 28,…
Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlights
Safety Review Committee clears MDNA11 Cohort 6 dose of 120µg/Kg, Q2W, in the Phase 1…
Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlights
Safety Review Committee clears MDNA11 Cohort 6 dose of 120µg/Kg, Q2W, in the Phase 1…
Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents
TORONTO, July 28, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents
TORONTO, July 28, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Curium Receives Marketing Authorization in the EU for PYLCLARI™, an Innovative 18F-PSMA PET Tracer Indicated in Adults With Prostate Cancer
PARIS, July 28, 2023 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced…